View in EDS

Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity.

Saved in:
Bibliographic Details
Title: Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity.
Authors: Zaryouh H; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium., De Pauw I; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium., Baysal H; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium., Melis J; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium., Van den Bossche V; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels B-1200, Belgium.; Institut Roi Albert II, Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Brussels B-1200, Belgium., Hermans C; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium., Lau HW; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium., Lambrechts H; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium., Merlin C; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium., Corbet C; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels B-1200, Belgium., Peeters M; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; Department of Medical Oncology, Antwerp University Hospital, Edegem 2650, Belgium., Vermorken JB; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; Department of Medical Oncology, Antwerp University Hospital, Edegem 2650, Belgium., De Waele J; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium., Lardon F; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; The authors contributed equally., Wouters A; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; The authors contributed equally.
Source: Cancer drug resistance (Alhambra, Calif.) [Cancer Drug Resist] 2023 Oct 17; Vol. 6 (4), pp. 709-728. Date of Electronic Publication: 2023 Oct 17 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: OAE Publishing Inc Country of Publication: United States NLM ID: 101738710 Publication Model: eCollection Cited Medium: Internet ISSN: 2578-532X (Electronic) Linking ISSN: 2578532X NLM ISO Abbreviation: Cancer Drug Resist Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38239393
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zaryouh+H%22">Zaryouh H</searchLink>; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.<br /><searchLink fieldCode="AU" term="%22De+Pauw+I%22">De Pauw I</searchLink>; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.<br /><searchLink fieldCode="AU" term="%22Baysal+H%22">Baysal H</searchLink>; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.<br /><searchLink fieldCode="AU" term="%22Melis+J%22">Melis J</searchLink>; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.<br /><searchLink fieldCode="AU" term="%22Van+den+Bossche+V%22">Van den Bossche V</searchLink>; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels B-1200, Belgium.; Institut Roi Albert II, Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Brussels B-1200, Belgium.<br /><searchLink fieldCode="AU" term="%22Hermans+C%22">Hermans C</searchLink>; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.<br /><searchLink fieldCode="AU" term="%22Lau+HW%22">Lau HW</searchLink>; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.<br /><searchLink fieldCode="AU" term="%22Lambrechts+H%22">Lambrechts H</searchLink>; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.<br /><searchLink fieldCode="AU" term="%22Merlin+C%22">Merlin C</searchLink>; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.<br /><searchLink fieldCode="AU" term="%22Corbet+C%22">Corbet C</searchLink>; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels B-1200, Belgium.<br /><searchLink fieldCode="AU" term="%22Peeters+M%22">Peeters M</searchLink>; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; Department of Medical Oncology, Antwerp University Hospital, Edegem 2650, Belgium.<br /><searchLink fieldCode="AU" term="%22Vermorken+JB%22">Vermorken JB</searchLink>; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; Department of Medical Oncology, Antwerp University Hospital, Edegem 2650, Belgium.<br /><searchLink fieldCode="AU" term="%22De+Waele+J%22">De Waele J</searchLink>; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.<br /><searchLink fieldCode="AU" term="%22Lardon+F%22">Lardon F</searchLink>; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; The authors contributed equally.<br /><searchLink fieldCode="AU" term="%22Wouters+A%22">Wouters A</searchLink>; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Campus Drie Eiken, Antwerp 2610, Belgium.; The authors contributed equally.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101738710%22">Cancer drug resistance (Alhambra, Calif.)</searchLink> [Cancer Drug Resist] 2023 Oct 17; Vol. 6 (4), pp. 709-728. <i>Date of Electronic Publication: </i>2023 Oct 17 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22OAE+Publishing+Inc%22">OAE Publishing Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101738710 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2578-532X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222578532X%22">2578532X </searchLink><i>NLM ISO Abbreviation: </i>Cancer Drug Resist <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38239393
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.20517/cdr.2023.62
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 709
    Titles:
      – TitleFull: Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zaryouh H
      – PersonEntity:
          Name:
            NameFull: De Pauw I
      – PersonEntity:
          Name:
            NameFull: Baysal H
      – PersonEntity:
          Name:
            NameFull: Melis J
      – PersonEntity:
          Name:
            NameFull: Van den Bossche V
      – PersonEntity:
          Name:
            NameFull: Hermans C
      – PersonEntity:
          Name:
            NameFull: Lau HW
      – PersonEntity:
          Name:
            NameFull: Lambrechts H
      – PersonEntity:
          Name:
            NameFull: Merlin C
      – PersonEntity:
          Name:
            NameFull: Corbet C
      – PersonEntity:
          Name:
            NameFull: Peeters M
      – PersonEntity:
          Name:
            NameFull: Vermorken JB
      – PersonEntity:
          Name:
            NameFull: De Waele J
      – PersonEntity:
          Name:
            NameFull: Lardon F
      – PersonEntity:
          Name:
            NameFull: Wouters A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 10
              Text: 2023 Oct 17
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2578-532X
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Cancer drug resistance (Alhambra, Calif.)
              Type: main
ResultId 1